Overview
A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
Background
A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
Indication
For use as a temporary measure in hospitalized patients with acute respiratory insufficiency superimposed on chronic obstructive pulmonary disease.
Associated Conditions
- Anesthetic complication pulmonary
- Acute Hypercapnia
- Drug-induced Respiratory depression
- Postoperative respiratory depression
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2025/06/15 | N/A | Recruiting | |||
2024/09/05 | Phase 1 | Not yet recruiting | |||
2020/06/12 | Phase 3 | Recruiting | |||
2019/03/28 | Not Applicable | UNKNOWN | |||
2016/06/30 | Not Applicable | UNKNOWN | General Hospital of Ningxia Medical University | ||
2014/06/24 | Phase 4 | Completed | |||
2009/12/01 | Phase 2 | Completed | |||
2007/05/23 | Phase 2 | Completed | |||
2006/10/19 | Phase 4 | Completed | Jean Michel Hascoet |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Hikma Pharmaceuticals USA Inc. | 0641-6018 | INTRAVENOUS | 20 mg in 1 mL | 2/19/2021 | |
HF Acquisition Co LLC, DBA HealthFirst | 51662-1404 | INTRAVENOUS | 20 mg in 1 mL | 2/22/2020 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
Doxapram Hydrochloride Injection | 国药准字H20054743 | 化学药品 | 注射剂 | 6/5/2020 | |
Doxapram Hydrochloride Injection | 国药准字H20033303 | 化学药品 | 注射剂 | 10/9/2020 | |
Doxapram Hydrochloride Injection | 国药准字H20056609 | 化学药品 | 注射剂 | 5/11/2020 | |
Doxapram Hydrochloride Injection | 国药准字H20093692 | 化学药品 | 注射剂 | 6/4/2024 | |
Doxapram Hydrochloride Injection | 国药准字H20068166 | 化学药品 | 注射剂 | 8/14/2020 | |
Doxapram Hydrochloride Injection | 国药准字H32022989 | 化学药品 | 注射剂 | 7/14/2020 | |
Doxapram Hydrochloride for Injection | 国药准字H20051761 | 化学药品 | 注射剂 | 7/23/2020 | |
Doxapram Hydrochloride for Injection | 国药准字H20080379 | 化学药品 | 注射剂 | 1/5/2023 | |
Doxapram Hydrochloride for Injection | 国药准字H20052657 | 化学药品 | 注射剂 | 4/28/2020 | |
Doxapram Hydrochloride for Injection | 国药准字H20060165 | 化学药品 | 注射剂 | 11/22/2022 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |